Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma.

Autor:	Diab, Osama, Mcentire, Dan, Kassim, Thamer, Nayfeh, Ali, Dajani, Abdel Rahman, Kerfeld, Mitchell, Campbell, Jonathon, Alsuwaidan, Adbullah, Hazeem, Mahmoud Abu, Gbadamosi-Akindele, Maryam
Předmět:	STEVENS-Johnson Syndrome CASTRATION-resistant prostate cancer PROSTATE cancer PROSTATE ADENOCARCINOMA METASTASIS
Zdroj:	Case Reports in Oncological Medicine; 1/9/2019, p1-4, 4p
Abstrakt:	Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.